Abzena will be exhibiting alongside our drug discovery partner Mabqi in booth #123 at PEGs Europe in Lisbon, Portugal from Nov. 11-13th.

Our Vice President of Business Development, Patrick Haddad will be on hand to discuss our fully integrated design, development and manufacturing capabilities that streamline and de-risk development for complex biologics and bioconjugates, including ADCs, AOCs, and bi/multi-specifics.

Schedule a meeting with Patrick while you’re at the conference to learn more about our newly enhanced cell line development platforms, and how they can improve that outcome of your biological program today!